Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.57 - $1.16 $24,920 - $50,715
-43,720 Reduced 7.58%
532,901 $325,000
Q1 2023

May 15, 2023

BUY
$1.06 - $1.97 $434,287 - $807,118
409,705 Added 245.46%
576,621 $640,000
Q4 2022

Feb 14, 2023

BUY
$1.4 - $25.4 $131,604 - $2.39 Million
94,003 Added 128.92%
166,916 $243,000
Q3 2022

Nov 14, 2022

BUY
$0.36 - $36.0 $26,248 - $2.62 Million
72,913 New
72,913 $133,000
Q1 2022

May 16, 2022

SELL
$16.6 - $32.3 $284,225 - $553,040
-17,122 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$29.9 - $61.2 $511,947 - $1.05 Million
17,122 New
17,122 $51,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $58M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.